Obesity Clinical Trial
— YESOfficial title:
Effectiveness and Safety of Weight Loss Surgery in Adolescents With Extreme Obesity Within a Structured Pre- and Post-surgery Treatment Program, Subproject 3
Verified date | May 2024 |
Source | University of Ulm |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The use of bariatric surgery in adolescents is controversial. On one side, bariatric surgery is the only effective treatment to achieve sustained weight loss in adults with extreme obesity. Comorbidities are reversed and mortality is reduced. In adolescents, bariatric surgery is equally effective; however, due to the paucity of long-term data, the long-term effects and risks are unknown. Thus, due to surgical risk and ethical implications, bariatric surgery is considered experimental in Germany. Nevertheless, case volumes are increasing. The aim of this study is to evaluate the benefits and risks of adolescent bariatric surgery in the context of a structured preparation and follow-up program. The study is a subproject of the study "Medical and psychosocial implications of adolescent extreme obesity - acceptance and effects of structured care" (DRKS00004172). At 5 German university centers (Ulm, Datteln, Berlin, Essen, Leipzig), youth who undergo bariatric surgery and are participants in the overall project will be enrolled in a structured preparation and follow-up program. The program is designed to improve adherence and compliance and will result in comprehensive follow-up data. In addition to the data gathered in the overall project, subjects participating in subproject 3 will undergo assessments pertinent to bariatric surgery, as proposed in the American Teen-LABS study (http://www.cincinnatichildrens.org/ research/divisions/t/teen-labs/default/). Comparison will be made with BMI matched adolescents who participate in the overall project but do not undergo bariatric surgery. In November 2014 recruitment for the overall project was completed. However, patients interested in bariatric surgery will still be recruited until September 2016. There assessment will be the same as for patients recruited earlier. However, in an amendment in December 2014, the frequency of assessment via questionnaire was reduced from biannually to annually. In addition, a travel reimbursement of 30€ for each study visit was implemented.
Status | Active, not recruiting |
Enrollment | 66 |
Est. completion date | January 2028 |
Est. primary completion date | April 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 14 Years to 24 Years |
Eligibility | Inclusion Criteria: - BMI = 35 kg/m2 with severe comorbidity or BMI = 40 kg/m2 with relevant comorbidity - completed longitudinal growth - stable social surroundings - exhaustion of conservative treatment - participation in the project "Adolescents with extreme Obesity" - adequate compliance and adherence Exclusion Criteria: - treatable causative condition - unstable medical, psychosocial or psychiatric comorbidity - alcohol or drug abuse - pregnancy - contraindication for bariatric surgery |
Country | Name | City | State |
---|---|---|---|
Germany | Ambulatory Obesity Program, Charité University, Berlin | Berlin | |
Germany | Vestische Kinderklinik, University of Witten/Herdecke | Datteln | |
Germany | University Duisburg-Essen | Essen | |
Germany | University Hospital Leipzig | Leipzig | |
Germany | Dept for Pediatrics and Adolescent Medicine, University of Ulm: Interdisciplinary obesity clinic | Ulm |
Lead Sponsor | Collaborator |
---|---|
Prof. Dr. Martin Wabitsch | Charite University, Berlin, Germany, Universität Duisburg-Essen, University of Leipzig, University of Witten/Herdecke |
Germany,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BMI change from baseline | 1 year postoperative | ||
Secondary | BMI | every 6 months for 9 years | ||
Secondary | changes in somatic comorbidity | Will be assessed via standardized physical examination, laboratory and apparative tests, and standardized patient questionnaires. | every 12 months for 9 years | |
Secondary | changes in psychosocial comorbidity | Will be assessed via standardized patient questionnaires. | every 12 months for 9 years | |
Secondary | changes in psychiatric comorbidity | Will be assessed via standardized psychiatric evaluation and standardized and validated patient questionnaires. | every 12 months for 9 years | |
Secondary | peri- und postoperative complications | Will be assessed via physician questionnaires. | every 12 months for 9 years | |
Secondary | vitamin deficiencies | Will be assessed via patient questionnaire and laboratory studies. | every 6 months for 9 years | |
Secondary | adherence with postoperative recommendations on supplements, doctors visits and nutrition | Will be assessed via patient questionnaire. | every 12 months for 9 years | |
Secondary | hunger, food tolerance, gastrointestinal symptoms, dumping | Will be assessed via patient questionnaire. | every 12 months for 9 years | |
Secondary | eating behavior | Will be assessed via validated questionnaire (EDE-Q). | every 12 months for 9 years | |
Secondary | exercise | Will be assessed via validated questionnaire (IPAQ). | every 12 months for 9 years | |
Secondary | changes in quality of life: SF36 | Will be assessed via validated questionnaires (SF36). | every 12 months for 9 years | |
Secondary | changes in quality of life: IWQOL | Will be assessed via validated questionnaires (IWQOL). | every 12 months for 9 years | |
Secondary | schooling, vocation, psychosocial situation, functional impairments | Will be assessed via standardized patient questionnaire. | every 12 months for 9 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |